AARD

Aardvark Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in San Diego, California, specializing in the development of innovative small-molecule therapies aimed at activating innate homeostatic pathways to effectively manage metabolic diseases. The company's robust research and development efforts underscore its commitment to addressing significant unmet medical needs, positioning Aardvark for substantial contributions to the biopharmaceutical sector. With a strong pipeline and a focus on rigorous clinical trials, Aardvark is poised to potentially transform the treatment landscape in its targeted therapeutic areas.